Journal Article

Antimicrobial and Antimotility Agent Use in Persons with Shiga Toxin–Producing <i>Escherichia coli</i> O157 Infection in FoodNet Sites

Jennifer M. Nelson, Patricia M. Griffin, Timothy F. Jones, Kirk E. Smith and Elaine Scallan

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 52, issue 9, pages 1130-1132
Published in print May 2011 | ISSN: 1058-4838
Published online May 2011 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1093/cid/cir087
Antimicrobial and Antimotility Agent Use in Persons with Shiga Toxin–Producing Escherichia coli O157 Infection in FoodNet Sites

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Antimicrobial and antimotility agents are not recommended for the treatment of Shiga toxin–producing Escherichia coli O157 infection. In our study, many persons with Shiga toxin–producing E. coli O157 infection took antimicrobial (62%) and antimotility agents (32%); 43 (29%) of 146 reported commencing antimicrobial treatment after laboratory confirmation. Efforts are needed to promote practice guidelines.

Journal Article.  1765 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.